KATIE PICKENS: Open Payments
NPI 1255160735 · EASTMAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| ABBVIE INC. | 9 | $159 |
| GlaxoSmithKline, LLC. | 7 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: BREZTRI, TRELEGY ELLIPTA, UBRELVY, QULIPTA, AIRSUPRA, VRAYLAR, CAPLYTA, OTEZLA.
Industry payments across GA — which companies pay providers there.
